Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

-Richard Kendall Researcher Activity Profile

Research Author Detailed Information 

Are you RICHARD KENDALL?? Join now for FREE! You can update this page and your profile image by registering at Molecular Stationrichard kendall

Richard Kendall Publication Rate By Year

Richard Kendall has published 1 paper(s) in 2006, 5 paper(s) in 2007, for a total of 6 research publications in total.

richard kendall researcher

Richard R Kendall Author Information

LAST NAME: kendall

FIRST NAME: richard

INITIALS: R

AFFILIATION:

Papers

Richard Kendall's Publication Record

  1. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts. Year Published: 2006
    2. Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA 91320-1799, USA. tonyp@amgen.com
  2. Discovery of N-phenyl nicotinamides as potent inhibitors of Kdr. Year Published: 2007
    3. Chemistry Research and Discovery, One Amgen Center Drive Thousand Oaks, CA 91320, USA. celia.dominguez@chdi-inc.org
  3. AMG 102, A Fully Human Anti-Hepatocyte Growth Factor/Scatter Factor Neutralizing Antibody, Enhances the Efficacy of Temozolomide or Docetaxel in U-87 MG Cells and Xenografts. Year Published: 2007
    4. Authors' Affiliation: Department of Oncology Research, Amgen, Inc., Thousand Oaks, California.
  4. AMG 102, a fully human anti-hepatocyte growth factor/scatter factor neutralizing antibody, enhances the efficacy of temozolomide or docetaxel in U-87 MG cells and xenografts. Year Published: 2007
    5. Department of Oncology Research, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91362, USA. tjun@amgen.com
  5. AMG 102, a fully human anti-hepatocyte growth factor/scatter factor neutralizing antibody, enhances the efficacy of temozolomide or docetaxel in U-87 MG cells and xenografts. Year Published: 2007
    6. Department of Oncology Research, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91362, USA. tjun@amgen.com
  6. Discovery of N-phenyl nicotinamides as potent inhibitors of Kdr. Year Published: 2007
    7. Chemistry Research and Discovery, One Amgen Center Drive Thousand Oaks, CA 91320, USA. celia.dominguez@chdi-inc.org
 

Molecular Station USER Menu

Welcome to Molecular Station!

You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

Already registered? Login now below.

User Name:

Password:

Already registered and Forgot your password? Click below to recover it.

Recover Lost Password

Join now - it's fast and free!

Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

Research Terms of Usage and Disclaimer
Home
Features

Protocols

DNA Forum

Science Forum

DNA Forum
Biology Forum

Science News


[CaRP] XML error: Invalid document end at line 2

For more click here:Science News